Skip to main content
. Author manuscript; available in PMC: 2022 Aug 4.
Published in final edited form as: Transplant Cell Ther. 2022 Apr 29;28(7):392.e1–392.e9. doi: 10.1016/j.jtct.2022.04.019

Table 5.

Clinical and Laboratory Features Associated with Increased Mortality Risk

Feature HR (95% CI) P Value
Univariate analysis
 Log sC5b-9 3.02 (1.48–6.15) .002
 ΔsC5b-9 from baseline to TA-TMA diagnosis 1.93 (1.32–2.83) .001
 Maximum rUPCR 1.01 (1.00–1.02) .068
 Number of injured organs 2.40 (1.67–3.35) .001
 Renal replacement therapy 40.75 (8.30–200.10) <.001
 Mechanical ventilation 11.16 (3.57–34.83) <.001
 Seizures 4.13 (1.17–14.53) .027
 Mental status changes 3.81 (1.32–11.00) .013
 GI bleeding 2.79 (0.90–8.63) .740
Multivariate analysis
 Log sC5b-9 2.70 (1.23–5.90) .013
 Maximum rUPCR 1.00 (0.99–1.02) .485